William Benton Jones Net Worth & Insider Trades

William Benton Jones - See Remarks, Corvus Pharmaceuticals, Inc

As of December 20, 2022

What is William Benton Jones's Net Worth?

The current estimated net worth of Corvus Pharmaceuticals, Inc's See Remarks, William Benton Jones, is estimated to be about $292.96K . William Benton Jones owns about 133,773 units of Corvus Pharmaceuticals, Inc common stock. In the last 6 years at Corvus Pharmaceuticals, Inc, William Benton Jones has sold an estimated value of $0 worth.

What is William Benton Jones's Past Insider Trading?

William Benton Jones's largest purchase order was 20,000 units , worth over $15.8K on December 20, 2022. In total, William Benton Jones has made about 9 transactions over 6 years of their time at Corvus Pharmaceuticals, Inc. William Benton Jones usually trades in December, with the busiest year in 2022 and 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

William Benton Jones

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is William Benton Jones's' Mailing Address?

  • Mailing address is 863 Mitten Road, Suite 102 Burlingame CA 94010 CA

What are Corvus Pharmaceuticals, Inc's Past Insider Trades?

Corvus Pharmaceuticals, Inc's most recent insider trade came on May 16, 2023 by Linda Grais who bought 10,000 units worth $24.5K . In the last 7 years, insiders at Corvus Pharmaceuticals, Inc have sold an estimated value of $52.82M and bought an estimated value of $84.18M worth of shares. Insider trading is most common in June, with the busiest year in 2016. The most active traders at the company are Richard A. Miller, President and CEO,  Peter A Thompson,  and Leiv Lea, Chief Financial Officer .

Corvus Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...